314 related articles for article (PubMed ID: 25715696)
1. A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.
Ji Y; Paus R; Prudic A; Lübbert C; Sadowski G
Pharm Res; 2015 Aug; 32(8):2559-78. PubMed ID: 25715696
[TBL] [Abstract][Full Text] [Related]
2. Influence of excipients on solubility and dissolution of pharmaceuticals.
Paus R; Prudic A; Ji Y
Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
[TBL] [Abstract][Full Text] [Related]
3. Influence of copolymer composition on the phase behavior of solid dispersions.
Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
[TBL] [Abstract][Full Text] [Related]
5. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
6. Influence of humidity on the phase behavior of API/polymer formulations.
Prudic A; Ji Y; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2015 Aug; 94():352-62. PubMed ID: 26117187
[TBL] [Abstract][Full Text] [Related]
7. Physical stability of API/polymer-blend amorphous solid dispersions.
Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
[TBL] [Abstract][Full Text] [Related]
8. Dissolution and precipitation behavior of amorphous solid dispersions.
Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
[TBL] [Abstract][Full Text] [Related]
9. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
[TBL] [Abstract][Full Text] [Related]
10. Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions.
Asare-Addo K; Alshafiee M; Walton K; Ward A; Totea AM; Taheri S; Mawla N; Adebisi AO; Elawad S; Diza C; Timmins P; Conway BR
Eur J Pharm Biopharm; 2019 Apr; 137():148-163. PubMed ID: 30836178
[TBL] [Abstract][Full Text] [Related]
11. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
12. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
[TBL] [Abstract][Full Text] [Related]
13. A novel approach for predicting the dissolution profiles of pharmaceutical tablets.
Paus R; Hart E; Ji Y
Eur J Pharm Biopharm; 2015 Oct; 96():53-64. PubMed ID: 26170163
[TBL] [Abstract][Full Text] [Related]
14. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
15. Investigating the Potential of Ethyl Cellulose and a Porosity-Increasing Agent as a Carrier System for the Formulation of Amorphous Solid Dispersions.
Everaerts M; Cools L; Adriaensens P; Reekmans G; Baatsen P; Van den Mooter G
Mol Pharm; 2022 Aug; 19(8):2712-2724. PubMed ID: 35476407
[TBL] [Abstract][Full Text] [Related]
16. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
Luebbert C; Wessner M; Sadowski G
Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
Paudel A; Loyson Y; Van den Mooter G
J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
[TBL] [Abstract][Full Text] [Related]
18. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
Liu X; Zhou L; Zhang F
Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
[TBL] [Abstract][Full Text] [Related]
19. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
Dhumal RS; Biradar SV; Aher S; Paradkar AR
J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
[TBL] [Abstract][Full Text] [Related]
20. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
Haser A; Cao T; Lubach J; Listro T; Acquarulo L; Zhang F
Eur J Pharm Sci; 2017 May; 102():115-125. PubMed ID: 28259831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]